Malignant neoplasm of rectum, including Hilmo

C3_RECTUM_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C20 Hospital discharge: ICD-9 — 154 Hospital discharge: ICD-8 — 1541 Cause of death: ICD-10 — C20 Cause of death: ICD-9 — 154 Cause of death: ICD-8 — 1541 Cause of death: excluded ICD-9 — 1540\|154[2-3] Cancer registry: Topography ICD-O-3 — C20 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	5272
4. Check minimum number of events None	5272
5. Include endpoints None	5272
6. Filter based on genotype QC (FinnGen only)	5118

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_RECTUM_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C20
HD_ICD_9	154
HD_ICD_8	1541
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C20
COD_ICD_9	154
COD_ICD_8	1541
COD_ICD_10_EXCL
COD_ICD_9_EXCL	1540\|154[2-3]
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C20
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of rectum, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5118	1993	3125
Unadjusted period prevalence (%)	1.15	0.71	1.43
Median age at first event (years)	67.96	66.34	68.99

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5272: Matched controls
52708

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A79

ICPC

Malignancy NOS

139.2

323.0

162

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

11.5

316.5

335

308

JN3AD

NOMESCO Finland

Abdominal CT examination

4.1

313.8

1000

2826

L02AE02

ATC

leuprorelin; implant, parenteral

50.3

311.9

180

H02AB02

ATC

dexamethasone; systemic

88.0

307.7

1509

239

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

19.5

307.7

769

457

XX3DW

NOMESCO Finland

Time consuming IT work

13.0

307.7

1161

1119

Z51.5

ICD-10 Finland

Palliative care

10.6

307.7

847

935

SPAT1125

SPAT

Stoma care and guidance

14.3

307.7

381

286

ZXC96

NOMESCO Finland

Robot assisted procedure

37.9

307.7

314

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

2718

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

7757.1

307.7

688

WX408

NOMESCO Finland

General anesthesy, balanced

4.1

307.7

2053

7165

D75

ICPC

Malignant neoplasm colon/rectum

722.9

307.7

636

N02AA05

ATC

oxycodone; systemic

4.3

307.7

1502

4498

A03FA01

ATC

metoclopramide; systemic, rectal

16.4

307.7

2668

3093

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

241.9

307.7

936

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

5.6

307.7

673

1338

JFF10

NOMESCO Finland

Loop enterostomy

111.1

307.7

274

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

1415.8

307.7

512

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

95.5

307.7

211

WZC00

NOMESCO Finland

Treatment plan or consultation

4.4

307.7

2497

8971

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

9.0

307.7

777

989

WZC30

NOMESCO Finland

Teaching

5.4

307.7

1432

3425

JN4BD

NOMESCO Finland

Extensive body CT

19.1

307.7

1629

1206

C61

ICD-10 Finland

Malignant neoplasm of prostate

445.9

307.7

486

UJG02

NOMESCO Finland

Proctoscopy

19.5

307.7

655

380

WX402

NOMESCO Finland

General anaesthesia

4.8

307.7

1700

4750

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

371.3

307.7

504

WF049

NOMESCO Finland

Radiotherapy of metastasis

1004.5

307.7

374

TJF80

NOMESCO Finland

Ostomy education

163.8

307.7

722

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

19.1

307.7

1443

1021

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

559.1

307.7

551

A04AA01

ATC

ondansetron; systemic, rectal

17.4

307.7

729

481

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

307.7

3524

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

307.7

326

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1126.3

307.7

852

A04AA02

ATC

granisetron; systemic, transdermal

1290.3

307.7

1273

JG1BG

NOMESCO Finland

MRI of rectum

703.9

307.7

780

WX600

NOMESCO Finland

Single shot through catheter

72.2

307.7

486

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

307.7

1123

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

307.7

4289

TPH07

NOMESCO Finland

Cathetrisation of artery

5.4

307.7

1321

3058

Z93

ICD-10 Finland

Artificial opening status

172.4

307.7

167

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

421

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

96.4

307.7

710

B01AB10

ATC

tinzaparin; parenteral

5.7

307.7

910

1852

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

103.1

307.7

329

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

307.7

520

JG1CG

NOMESCO Finland

Extensive MRI of rectum

439.7

307.7

621

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

132.6

307.7

347

L01BC06

ATC

capecitabine; oral

+∞

307.7

2230

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

380.9

307.7

607

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

307.7

647

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

9.3

307.7

537

632

UJF32

NOMESCO Finland

Coloscopy

9.5

307.7

3484

9008

Z43.3

ICD-10 Finland

Attention to colostomy

169.2

307.7

164

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

24.6

307.7

2531

1905

TPX10

NOMESCO Finland

Implantation of vascular injection port

11.7

307.7

411

379

WX302

NOMESCO Finland

Thoracal epidural anesthesy

54.2

307.7

1698

458

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

8406.6

307.7

737

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

454.5

307.7

568

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

1175.5

307.7

331

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

307.7

890

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

307.7

453

WF002

NOMESCO Finland

Radical radiotherapy

166.8

307.7

526

JN4CD

NOMESCO Finland

Very extensive body CT

17.0

307.7

465

299

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

1386.6

307.7

386

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

43.0

307.7

254

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

16140.3

307.7

2585

B01AB05

ATC

enoxaparin; parenteral

5.4

307.7

2973

10188

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

599

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

9029.0

307.7

783

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

172.0

307.7

427

L03AA02

ATC

filgrastim; parenteral

81.9

307.7

182

Z93.3

ICD-10 Finland

Colostomy status

138.1

307.7

622

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

2091.8

307.7

367

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

307.7

586

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2290.2

307.7

573

C20

ICD-10 Finland

Malignant neoplasm of rectum

8526.8

307.7

1316

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

180.9

307.7

175

JFF23

NOMESCO Finland

Transversostomy

258.2

307.7

1071

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

29.4

307.7

915

374

JN4AD

NOMESCO Finland

Body CT examination

12.5

307.7

1354

1418

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

182.7

307.7

244

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

793.2

307.4

300

ZX090

NOMESCO Finland

Other technic of radiotherapy

358.6

306.7

307

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

305.2

290

ZX070

NOMESCO Finland

Intensity modified radiotherapy

782.0

303.2

296

ZXE20

NOMESCO Finland

More than three and less than five hours

3.7

303.1

1164

3739

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

299.9

285

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

2864.7

294.3

282

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

14.3

294.0

271

199

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

10.5

288.3

325

327

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

972.8

284.9

277

A04AA55

ATC

palonosetron, combinations; systemic

+∞

283.9

270

WF004

NOMESCO Finland

Palliative radiotherapy

2732.2

281.5

270

116

Kela drug reimbursment

Prostate cancer

+∞

280.7

267

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

278.6

265

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

928.3

272.2

265

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.9

249.8

598

1343

ZX120

NOMESCO Finland

Intravenous

4.3

249.1

721

1881

WW500

NOMESCO Finland

Blood transfusion

8.3

245.3

331

420

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

290.2

244.9

248

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

240.4

229

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.3

235.4

671

1728

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

36.3

232.3

145

JF2AB

NOMESCO Finland

Colongraphy with X-ray

55.9

231.9

131

D18

ICPC

Change in faeces/bowel movements

7.6

228.0

332

460

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.7

226.5

801

2404

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

51.2

226.1

130

WF003

NOMESCO Finland

Adjuvant radiotherapy

335.4

225.8

227

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

39.0

223.7

137

WX306

NOMESCO Finland

Lumbar epidural anesthesy

5.6

219.9

439

839

L01BC59

ATC

trifluridine, combinations; systemic

+∞

216.1

206

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

215.1

205

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

16.5

213.9

181

113

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

87.2

210.6

111

R4110

NOMESCO Finland

Physiotherapy

2.6

208.9

1800

8874

L02BG04

ATC

letrozole; oral

36.0

207.7

130

JAH00

NOMESCO Finland

Laparotomy

7.2

206.7

318

468

115

Kela drug reimbursment

Breast cancer

+∞

201.3

192

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

45.1

201.3

119

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

9.5

200.3

241

264

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.4

193.9

810

2694

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

4.8

190.6

458

1026

JFB00

NOMESCO Finland

Partial resection of small intestine

9.8

189.2

222

235

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

11.4

188.6

199

181

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

1997.1

188.5

182

L03AA13

ATC

pegfilgrastim; parenteral

479.5

187.4

186

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

6.2

187.4

332

565

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.8

185.1

353

645

PJA12

NOMESCO Finland

Sentinel node biopsy

626.3

184.9

182

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

183.4

175

A04AD12

ATC

aprepitant; systemic

919.4

182.4

178

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

180.3

1443

6795

TQW40

NOMESCO Finland

Remowal of suture of skin

3.9

178.8

564

1553

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

20.5

178.3

136

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

178.1

170

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

14.2

177.7

163

118

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

24.3

177.2

126

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

177.1

169

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

174.9

167

D99

ICPC

Disease digestive system other

11.9

172.5

176

152

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.6

169.3

421

968

ZZR00

NOMESCO Finland

Flap of skin

15.0

168.4

150

103

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

341.7

166.1

167

ZX080

NOMESCO Finland

Image guided radiotherapy

1708.9

165.4

160

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

30.3

162.5

107

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

45.5

159.4

Z51.0

ICD-10 Finland

Radiotherapy session

780.8

155.2

152

K56.7

ICD-10 Finland

Ileus, unspecified

7.2

153.0

232

335

JGB36

NOMESCO Finland

Wide excision of rectum

1556.6

152.8

148

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

149.7

143

Z93.2

ICD-10 Finland

Ileostomy status

25.3

145.7

102

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

16.1

144.0

123

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1444.6

143.4

139

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

141.3

135

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

141.3

135

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

140.2

134

369

Kela drug reimbursment

Regorafenib

+∞

140.2

134

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

139.2

133

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

1370.9

137.1

133

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

44.5

133.2

JFB30

NOMESCO Finland

Right hemicolectomy

13.5

131.5

124

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

23.0

130.9

A06AH03

ATC

naloxegol; oral

15.7

129.2

112

176

Kela drug reimbursment

Regorafenib

+∞

128.6

123

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

24.7

127.4

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

15.6

126.6

110

SPAT1262

SPAT

Handing over of treatment supplies

2.3

124.0

1263

6472

B01AB04

ATC

dalteparin; parenteral

3.8

122.9

402

1128

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

17.1

122.1

101

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

121.3

116

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

6.0

121.1

217

372

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

120.2

115

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.6

119.6

232

429

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

119.5

779

3263

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.7

119.2

408

1180

L02BA01

ATC

tamoxifen; oral

53.0

118.9

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.4

118.3

100

R4190

NOMESCO Finland

Nutritional therapy

5.6

116.7

226

417

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

6.6

116.7

192

302

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

392.6

116.0

116

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

115.0

110

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

114.3

1972

12244

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.1

114.0

247

504

Y77

ICPC

Malignant neoplasm prostate

237.1

113.2

116

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

21.3

112.2

D70.82

ICD-10 Finland

Drug-induced neutropenia

17.8

112.1

JFF26

NOMESCO Finland

Sigmoidostomy

44.5

111.2

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

110.8

106

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

375.1

110.8

111

NK6AN

NOMESCO Finland

Total body bone isotope imaging

26.6

110.5

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

109.7

105

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.0

108.5

325

856

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.0

106.5

321

849

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

106.4

252

554

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

55.1

105.7

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

347.2

102.5

103

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.9

101.5

187

329

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

19.8

100.9

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.3

100.8

273

667

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

340.2

100.4

101

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.5

100.4

199

375

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

100.3

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

22.4

99.5

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

99.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

976.3

98.4

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

98.2

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

98.2

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

97.2

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

252.2

97.0

WZC15, ,

NOMESCO Finland

39.8

96.7

N03AX16

ATC

[U] pregabalin

2.0

95.5

1344

7685

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

945.2

95.2

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

7.3

95.2

140

195

N02BE01

ATC

paracetamol; systemic, rectal

2.4

94.6

4643

39728

Z43.2

ICD-10 Finland

Attention to ileostomy

115.5

94.3

102

1XC07, ,

NOMESCO Finland

+∞

94.0

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

+∞

94.0

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

17.9

94.0

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.3

93.1

137

191

HAC20

NOMESCO Finland

Total mastectomy

142.6

92.3

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

92.2

938

4743

L02BB03

ATC

bicalutamide; oral

+∞

91.9

JFF24

NOMESCO Finland

Laparoscopic transversostomy

460.6

91.5

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

11.5

91.5

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

903.7

91.1

Z31.5

ICD-10 Finland

Genetic counselling

4.6

90.6

220

493

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

893.4

90.0

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

13.3

89.6

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

27.6

88.3

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.7

88.2

286

795

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.0

87.9

430

1540

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

19.7

87.7

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

41.2

87.6

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

434.6

86.3

WX704

NOMESCO Finland

Intubation

2.8

86.3

481

1848

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

84.6

JAH01

NOMESCO Finland

Laparoscopy

4.2

84.6

233

576

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

49.4

84.3

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

83.5

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

83.5

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

16.0

82.9

D16

ICPC

Rectal bleeding

4.5

82.7

205

467

XX1AD

NOMESCO Finland

Other CT-examination

147.4

82.2

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

12.5

80.4

C209, 8148, 2

ICD-O-3

143.9

80.2

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.8

79.2

125

188

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

8.1

79.2

107

135

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.6

79.0

129

201

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

28.2

78.5

Z3231

NOMESCO Finland

Registered nurse

1.8

76.5

1443

8984

UJF30

NOMESCO Finland

Ileoscopy through colon

2.4

75.9

606

2756

E0000UV, ,

ATC

1.7

75.9

2053

14186

ZX121

NOMESCO Finland

Central venous catheter

34.6

75.7

K92.1

ICD-10 Finland

Melaena

2.8

75.6

420

1608

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

26.2

75.2

TPX15

NOMESCO Finland

Removal of vascular injection port

22.2

74.7

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.2

74.7

303

972

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

20.9

74.2

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

253.7

73.5

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

91.4

73.1

XX2RW, ,

NOMESCO Finland

11.0

73.0

KC1GB

NOMESCO Finland

Cystography with X-ray

30.3

72.7

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

10.7

72.5

TJG20

NOMESCO Finland

Transanal irrigation

25.2

71.3

HA1AA

NOMESCO Finland

X-ray mammography

4.3

71.2

189

454

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

71.0

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

71.0

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

4.7

70.7

167

366

ZX050

NOMESCO Finland

Stereotactic radiotherapy

32.4

69.6

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

687.1

69.2

C50.99

ICD-10 Finland

Breast, unspecified

687.1

69.2

D17

ICPC

Incontinence of bowel

6.6

68.8

112

174

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

666.6

67.1

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

666.6

67.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

67.0

2454

18189

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

22.5

66.8

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

66.8

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

11.1

66.8

KCD02

NOMESCO Finland

Transurethral resection of bladder

9.4

65.4

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

226.1

65.3

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

+∞

64.7

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.7

64.6

153

336

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

169.6

64.1

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.9

64.0

144

303

WGA11

NOMESCO Finland

Planning of pain management

13.5

63.9

L01BC53

ATC

tegafur, combinations; systemic

+∞

63.7

L01XE21

ATC

[U] regorafenib

+∞

63.7

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

30.2

63.6

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

63.4

1907

13388

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

63.3

460

2000

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

315.7

62.5

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.5

62.3

122

227

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.2

62.3

167

404

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.7

61.8

200

554

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

61.6

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

61.6

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

61.6

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

18.3

61.2

ZZR10

NOMESCO Finland

Flap of skin and muscle

16.6

60.8

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

16.6

60.8

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

6.3

60.7

103

167

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

60.5

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

60.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

60.5

1421

9320

R50.9

ICD-10 Finland

Fever, unspecified

2.0

60.4

736

3934

G04BE03

ATC

sildenafil; oral

8.8

59.9

D28

ICPC

Limited function/disability (D)

14.9

59.6

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

59.5

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.5

59.1

206

600

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

58.4

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

125.4

57.9

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

125.4

57.9

J01MA12

ATC

levofloxacin; systemic

1.8

57.6

992

5935

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

195.4

56.1

JHA00

NOMESCO Finland

Anal or perianal incision

5.6

56.1

106

191

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

79.8

56.0

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.8

55.8

302

1137

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.4

55.5

205

620

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

55.2

469

2179

A02BC02

ATC

pantoprazole; systemic

1.6

54.8

3399

28024

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

543.5

54.6

V03AF03

ATC

calcium folinate; systemic

543.5

54.6

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.6

54.5

129

283

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

54.4

1008

6154

P01AB01

ATC

metronidazole; oral, rectal

1.6

54.1

1823

13036

L03AA14

ATC

lipegfilgrastim; parenteral

533.3

53.6

JHA10

NOMESCO Finland

Biopsy of anal canal

21.2

53.2

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

53.2

6434

FHL

Anterior resection

85.3

53.0

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

21.8

52.5

S18

ICPC

Laceration/cut

1.6

52.4

2280

17266

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

9.5

52.4

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

52.2

JEA00

NOMESCO Finland

Appendectomy

2.7

52.0

302

1178

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

7.1

52.0

111

OAB50, ,

SPAT

2.4

51.4

360

1537

L01EX05

ATC

regorafenib; oral

+∞

51.1

JFB20

NOMESCO Finland

Ileocaecal resection

11.1

51.0

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.3

50.8

131

308

JFB43

NOMESCO Finland

Left hemicolectomy

10.7

50.6

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

19.6

50.2

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

50.1

Z71.8

ICD-10 Finland

Other specified counselling

1.6

50.0

1379

9352

ZXD05

NOMESCO Finland

Urgent procedure

1.6

49.9

1518

10545

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.9

49.8

110

228

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

49.4

3182

26138

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

49.0

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

6.4

49.0

128

UJF34

NOMESCO Finland

Left colonoscopy

7.9

48.9

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

48.0

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

48.0

UKC02

NOMESCO Finland

Cystoscopy

1.8

48.0

891

5424

JJB30

NOMESCO Finland

Excision of two segments of liver

168.2

47.9

D77

ICPC

Malignant digestive neopl other/NOS

105.0

47.8

D29

ICPC

Digestive symptom/complaint other

3.8

47.8

148

398

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

47.7

284

1121

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

11.2

47.5

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

46.9

330

1411

JFB46

NOMESCO Finland

Resection of sigmoid colon

5.6

46.4

159

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

461.8

46.3

KA3EB

NOMESCO Finland

Antegrade pyelography

11.8

46.3

J01MA02

ATC

ciprofloxacin; systemic

1.5

46.1

1993

14943

UJH02

NOMESCO Finland

Anoscopy

2.7

46.1

248

930

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

237.0

46.0

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

10.1

46.0

C209, ,

ICD-10 Finland

+∞

45.9

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

45.9

6435

FHL

Abdominoperineal resection and colostomy

161.4

45.9

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

44.5

290

1196

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

58.3

44.4

ZXE00

NOMESCO Finland

One hour or less

1.5

44.2

1775

13065

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

43.8

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

43.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

43.8

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.4

43.7

111

258

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

43.6

610

3396

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.7

43.3

101

219

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

14.5

43.3

JAL30

NOMESCO Finland

Omentectomy

11.0

43.3

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

221.8

43.0

8070/3-C20.9

ICD-O-3

Squamous cell carcinoma, NOS, of rectum, NOS

+∞

42.8

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

9.7

42.1

8000/3-C20.9

ICD-O-3

Neoplasm, malignant of rectum, NOS

+∞

41.7

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

41.7

ZX112

NOMESCO Finland

Subcutaneous

6.0

41.1

124

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

40.9

147

437

K61.1

ICD-10 Finland

Rectal abscess

10.8

40.8

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

8.6

40.8

SPAT1109

SPAT

Analgesia with portable analgesic pump

10.1

40.7

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

40.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

40.3

385

1869

JFA70

NOMESCO Finland

Suture of small intestine

11.8

40.3

C50

ICD-10 Finland

Malignant neoplasm of breast

400.5

40.1

128

Kela drug reimbursment

Cancers of female genital organs

400.5

40.1

JFF13

NOMESCO Finland

Terminal enterostomy

14.5

39.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

39.8

748

4550

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

39.6

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

39.6

JFB50

NOMESCO Finland

Other resection of colon

13.9

39.0

LEC00

NOMESCO Finland

Partial excision of vagina

74.1

38.9

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

38.6

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

38.6

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

38.6

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

380.1

38.1

N02AX02

ATC

tramadol; systemic, rectal

1.5

38.0

2089

16269

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.7

37.8

124

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

37.5

ZXC40

NOMESCO Finland

Use of ultrasound

8.9

37.2

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

37.1

389

1955

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

369.9

37.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

36.8

806

5104

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.3

36.7

141

437

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

36.5

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

36.5

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

36.5

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.1

36.4

154

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.8

36.2

115

JKA20

NOMESCO Finland

Cholecystectomy

2.9

36.0

176

627

A06AD11

ATC

lactulose; oral

1.7

35.8

829

5324

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

10.6

35.7

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.0

35.6

157

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

35.4

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

35.4

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

35.4

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.9

35.3

JAD10

NOMESCO Finland

Repair of incisional hernia

5.7

35.3

118

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.9

35.1

105

276

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

124.2

34.7

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

10.9

34.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

34.5

1547

11523

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

51.6

34.4

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

34.4

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

+∞

34.4

KBV00

NOMESCO Finland

Insertion of stent into ureter

7.0

34.3

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.2

34.1

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

34.1

272

1227

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

176.1

33.7

WX892

NOMESCO Finland

Monitored bed care

2.0

33.6

412

2188

L02BX02

ATC

degarelix; parenteral

+∞

33.4

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

33.4

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

33.4

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

33.4

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

33.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

33.3

711

4462

L02AE03

ATC

goserelin; implant

10.3

33.3

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.2

33.3

C209, 8211, 2

ICD-O-3

56.1

33.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

33.2

373

1922

SPAT1153

SPAT

Removal of sutures

1.5

32.5

1497

11180

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

32.3

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

32.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

32.3

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

32.3

117

350

XKD00

NOMESCO Finland

Uroflowmetry

1.6

32.2

847

5602

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

62.1

32.0

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

318.9

31.9

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

4.4

31.5

178

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.4

31.3

183

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

5.3

31.3

117

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

31.3

8070/3-C21.1

ICD-O-3

Squamous cell carcinoma, NOS, of anal canal

+∞

31.3

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

31.3

WX610

NOMESCO Finland

Patient controlled analgesia

7.7

31.0

LCD00

NOMESCO Finland

Hysterectomy

2.6

31.0

180

702

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

31.0

201

827

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.4

30.9

210

882

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

7.3

30.9

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.9

30.8

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

10.4

30.7

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

30.2

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

58.7

30.1

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

58.7

30.1

K62.1

ICD-10 Finland

Rectal polyp

3.9

29.9

224

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

32.7

29.9

UJF32, ,

SPAT

2.7

29.8

157

583

R19.4

ICD-10 Finland

Change in bowel habit

2.7

29.7

162

612

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

107.3

29.7

L02BG03

ATC

anastrozole; oral

107.3

29.7

R33

ICD-10 Finland

Retention of urine

1.8

29.6

498

2920

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

30.2

29.4

JFF30

NOMESCO Finland

Other colostomy

30.2

29.4

K62.7

ICD-10 Finland

Radiation proctitis

+∞

29.2

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

29.2

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

40.3

28.9

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

293.5

28.8

X76

ICPC

Malignant neoplasm breast female

103.9

28.7

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

150.8

28.7

WX002

NOMESCO Finland

Sedation and analgesia

1.5

28.6

926

6409

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

28.4

131

453

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.2

28.2

185

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

28.1

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

28.1

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

28.1

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

28.1

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

28.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

28.0

365

1976

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.5

28.0

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

64.3

27.9

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.1

27.8

114

368

JFA42

NOMESCO Finland

Endoscopic injection in colon

6.6

27.6

JGA98

NOMESCO Finland

Other transluminal endoscopic local operation on rectum

35.2

27.4

G04CA02

ATC

tamsulosin; oral

1.4

27.4

1526

11737

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.2

27.2

108

342

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.8

27.2

217

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

53.6

27.2

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.9

27.1

121

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

27.1

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

27.1

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

27.1

Z3226

NOMESCO Finland

Physiotherapist

1.6

27.0

819

5578

KBH20

NOMESCO Finland

Replantation of ureter

23.9

26.9

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

62.3

26.9

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

9.7

26.8

JN6AD

NOMESCO Finland

CT of torso and neck

5.5

26.7

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

140.7

26.6

1XC08, ,

NOMESCO Finland

+∞

26.1

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

26.1

WX882

NOMESCO Finland

High dependency care

2.6

26.0

151

589

XJH00

NOMESCO Finland

Transanal ultrasonography

1.9

25.8

326

1748

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

25.6

269

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.7

25.6

217

NET99

NOMESCO Finland

Other operation on pelvis

135.7

25.6

L02AE04

ATC

triptorelin; parenteral

135.7

25.6

K83.1

ICD-10 Finland

Obstruction of bile duct

4.6

25.2

133

WVA20

NOMESCO Finland

Medicine administration

2.8

25.1

127

462

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

25.0

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

25.0

8210/3-C20.9

ICD-O-3

Adenocarcinoma in adenomatous polyp of rectum, NOS

+∞

25.0

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

25.0

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

21.3

24.7

Z2221

NOMESCO Finland

Medical doctor

1.4

24.4

1142

8479

K56.0

ICD-10 Finland

Paralytic ileus

3.7

24.2

212

R11

ICD-10 Finland

Nausea and vomiting

1.8

24.0

362

2052

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

56.3

24.0

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

56.3

24.0

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

24.0

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

24.0

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

24.0

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

24.0

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

24.0

A28

ICPC

Limited function/disability NOS

1.5

23.9

927

6638

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

26.8

23.5

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

23.5

248

1248

JAG00

NOMESCO Finland

Repair of other hernia

21.4

23.4

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.4

23.3

133

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.8

23.2

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

23.1

529

3365

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

4.0

23.0

160

S77

ICPC

Malignant neoplasm of skin

18.5

23.0

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

22.9

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

22.9

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

22.9

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

22.9

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

22.9

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

22.9

180

807

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

22.8

300

1630

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

22.7

503

3174

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.5

22.6

124

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.1

22.6

220

1075

Z2446

NOMESCO Finland

Social worker

2.0

22.5

253

1302

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

22.3

358

2068

KBV10

NOMESCO Finland

Removal of stent from ureter

4.8

22.2

102

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

3.6

22.2

201

R15

ICD-10 Finland

Faecal incontinence

2.4

22.0

150

632

8070/3-C21.0

ICD-O-3

Squamous cell carcinoma, NOS, of anus, NOS

+∞

21.9

8144/3-C20.9

ICD-O-3

Adenocarcinoma, intestinal type of rectum, NOS

+∞

21.9

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

21.9

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

21.9

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

21.9

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

21.9

KA1FN

NOMESCO Finland

Isotope renography

6.2

21.9

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

62.8

21.8

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

22.3

21.7

GDB10

NOMESCO Finland

Wedge resection of lung

26.5

21.3

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

6.6

21.3

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

21.0

680

4679

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

21.0

881

11827

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

20.9

181

845

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

20.8

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

20.8

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

20.8

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

20.8

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

20.8

L02BB04

ATC

enzalutamide; oral

+∞

20.8

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

3.9

20.7

159

R03AC02

ATC

salbutamol; inhalant

0.7

20.7

1683

20346

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

77.1

20.7

Z93.8

ICD-10 Finland

Other artificial opening status

210.8

20.6

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

210.8

20.6

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

210.8

20.6

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

210.8

20.6

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

110.4

20.6

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

18.3

20.4

GDC00

NOMESCO Finland

Lobectomy of lung

20.1

20.3

R18

ICD-10 Finland

Ascites

3.1

20.1

280

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

20.1

914

12120

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.4

20.1

144

621

C10AX09

ATC

ezetimibe; oral

0.6

20.0

409

6380

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

19.9

209

1050

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

57.7

19.9

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

19.9

172

803

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

19.8

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

19.8

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

19.8

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

19.8

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

19.8

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

19.8

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

19.8

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

19.8

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

73.7

19.7

L02BG06

ATC

exemestane; oral

200.7

19.6

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

200.7

19.6

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.9

19.5

148

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

21.6

19.5

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

19.4

814

10960

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.9

19.4

N02BF02

ATC

pregabalin; oral

1.9

19.3

249

1343

PJA10

NOMESCO Finland

Exploration of lymph nodes

5.8

19.3

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

31.4

19.2

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

19.2

182

881

A07DA03

ATC

loperamide; oral

2.1

19.1

176

842

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1150

770

18.82

307.65

5.6

1.8

493.14

20.84

u/ml

0.84

1057

608

(3002256) Pathology report gross observation

1209

2942

5.03

307.65

1.3

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1551

2971

6.98

307.65

2.2

2.0

0.22

0.20

g/l

6.78

1507

2672

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3629

17177

4.57

307.65

3.8

2.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1582

4063

5.13

307.65

2.6

2.2

7.20

8.25

umol/l

1.04

1468

3484

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1324

3356

4.93

307.65

2.1

2.2

32.01

52.21

u/l

0.79

1202

2830

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2331

8716

4.00

307.65

3.3

2.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3638

20884

3.39

307.65

12.6

19.2

1.22

1.37

inr

21.02

956

5785

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3889

19755

4.69

307.65

13.7

3.8

11.03

12.26

umol/l

6.94

3821

18447

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3906

2096

69.05

307.65

8.9

1.4

34.79

2.67

ug/l

3.67

3546

1558

(40768804) Tissue Pathology biopsy report

2699

12253

3.46

307.65

2.7

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

546

449

13.45

307.65

4.9

1.9

54.87

24.34

u/ml

2.95

492

408

(3022145) Colonoscopy Study observation

2321

4037

9.48

307.65

1.7

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

2210

9573

3.25

307.65

5.0

3.6

89.18

85.16

11.90

2194

9301

(3024561) Albumin [Mass/volume] in Serum or Plasma

3602

17229

4.44

307.65

10.0

3.9

33.45

35.40

g/l

72.55

3505

15688

(3044640) Blood type and Crossmatch panel - Blood

2790

11418

4.06

307.65

3.5

2.2

—

(4035726) Immunohistochemistry procedure

1169

1029

14.31

307.65

1.4

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3481

21432

2.84

274.68

16.2

6.3

3.90

4.38

e9/l

29.12

3065

18324

(3023368) Bacteria identified in Blood by Culture

2272

11508

2.71

261.05

5.2

3.9

—

(3003694) ABO and Rh group [Type] in Blood

1935

9272

2.72

245.15

1.4

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4319

30893

3.20

238.55

15.3

5.4

87.98

75.84

u/l

33.34

4221

28500

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

774

2203

3.94

236.78

8.9

10.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2289

12109

2.57

234.41

4.1

2.6

30.96

35.05

u/l

1.81

2228

11352

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2361

12863

2.51

224.60

2.6

2.3

57.48

60.39

u/l

1.69

2276

11743

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1050

4082

2.96

192.36

8.3

8.1

117.47

122.88

g/l

16.53

1028

3974

(3015377) Calcium [Moles/volume] in Serum or Plasma

2251

12897

2.30

180.52

7.6

2.1

2.35

mmol/l

0.73

2074

10762

(3016502) Oxygen saturation in Arterial blood

1097

4546

2.78

177.08

8.0

7.6

97.17

95.10

25.70

1062

4373

(3014111) Lactate [Moles/volume] in Serum or Plasma

955

3717

2.92

173.13

6.6

6.9

1.20

1.43

mmol/l

9.25

937

3613

(3027801) Oxygen [Partial pressure] in Arterial blood

1155

5040

2.65

167.48

7.8

7.2

14.91

11.53

kpa

62.50

1118

4792

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1155

5044

2.65

167.19

7.8

7.3

5.21

5.04

kpa

9.68

1120

4808

(3003396) Base excess in Arterial blood by calculation

1150

5019

2.65

166.62

7.9

7.3

0.64

1.27

mmol/l

6.91

1006

3956

(3014007) Fractional oxyhemoglobin in Arterial blood

758

2665

3.15

163.96

8.4

9.4

95.55

93.38

22.54

758

2652

(3013826) Glucose [Moles/volume] in Serum or Plasma

3518

24776

2.26

163.40

6.1

4.6

6.98

6.90

mmol/l

1.57

3408

23165

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1495

7494

2.39

160.12

8.6

2.2

2.48

2.45

mmol/l

21.71

1394

6392

(3002582) Erythrocytes [#/volume] in Urine

2124

12342

2.21

159.56

3.6

3.1

83.79

92.04

e6/l

0.10

1659

9436

(3037121) Protein [Mass/volume] in Urine

487

1332

3.93

155.25

6.0

2.5

0.22

0.35

g/l

4.41

370

468

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3066

20720

2.15

154.12

8.4

5.9

1.19

1.21

mmol/l

39.49

2659

17475

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2850

18776

2.13

152.61

7.5

5.5

1.19

1.21

mmol/l

32.59

2664

16677

(3030467) Casts [#/volume] in Urine by Automated count

1980

11356

2.19

151.97

3.5

3.0

0.48

0.47

e6/l

0.09

1529

8633

(3000991) Gas panel - Venous blood

874

3479

2.81

150.40

7.5

8.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

734

2669

3.03

149.00

8.4

9.4

0.62

0.69

6.70

729

2650

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

736

2688

3.02

148.21

8.4

9.2

1.27

1.43

3.28

731

2673

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1264

6060

2.43

148.10

5.5

2.5

0.79

0.82

mmol/l

23.98

1205

5548

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

634

2151

3.21

144.79

8.7

9.7

23.95

24.40

mmol/l

3.18

625

2063

(36304419) Bacteria [Presence] in Urine

1881

10899

2.13

137.59

3.4

3.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

473

1413

3.58

131.94

2.5

3.2

0.29

0.34

u/ml

2.68

227

838

(40758558) Short blood count panel - Blood

1621

9031

2.15

129.89

12.8

4.8

—

(3018095) Leukocytes [#/volume] in Urine

2246

14320

1.99

122.78

4.2

3.5

155.80

112.77

e6/l

1.24

1716

10175

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

710

2807

2.77

122.24

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1238

6407

2.22

117.89

3.2

2.8

2.63

2.14

e6/l

0.77

686

3544

(3031040) Bacteria [#/volume] in Urine by Automated count

3524

26601

1.98

113.11

5.0

4.4

2413.20

1862.28

e6/l

0.14

423

(3042936) Bacteria identified in Isolate by Culture

1079

5696

2.12

95.32

2.3

2.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1254

7035

2.03

93.79

3.0

2.6

1.06

1.19

e6/l

0.57

694

4148

(3026782) Osmolality of Urine

1375

8192

1.92

85.12

3.5

2.8

524.56

547.35

mosm/kgh2o

3.77

1235

6913

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1056

5770

2.04

83.86

2.2

2.7

20.00

22.44

6.08

916

4819

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1100

6156

1.99

81.40

2.2

2.6

2.35

2.29

g/l

2.78

1038

5621

(3026008) Bacteria identified in Urine by Culture

1865

12394

1.78

80.19

3.5

3.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1161

6678

1.95

79.05

2.3

2.6

11.53

12.82

umol/l

6.42

1103

6119

(3000850) Epithelial cells [#/volume] in Urine

1408

8660

1.85

77.82

2.8

2.5

5.01

4.45

e6/l

0.69

1293

7673

(3020779) Urea [Moles/volume] in Serum or Plasma

727

3878

2.01

60.02

5.1

7.1

9.42

11.16

mmol/l

7.62

698

3661

(3006504) Eosinophils/100 leukocytes in Blood

2396

18002

1.61

59.41

4.8

5.6

2.73

2.99

5.95

2235

16514

(3019069) Monocytes/100 leukocytes in Blood

2406

18111

1.60

59.08

5.1

5.9

9.03

8.84

1.80

2245

16645

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4572

40557

1.96

58.84

28.6

13.9

36.42

24.69

mg/l

91.92

4279

31898

(3022096) Basophils/100 leukocytes in Blood

2335

17468

1.60

58.73

4.7

5.7

0.57

0.67

15.86

2174

16008

(40768800) Prostate Pathology biopsy report

123

246

5.09

57.99

1.2

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3427

28143

1.62

57.76

5.5

4.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

2442

18519

1.59

57.61

4.9

5.8

22.99

26.77

44.56

2275

17073

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1575

10793

1.65

55.95

2.2

2.3

3.32

2.95

mg/l

4.90

1342

9093

(3048689) Calprotectin [Mass/mass] in Stool

741

4120

1.93

53.85

1.6

2.2

270.04

156.57

ug/g

6.74

586

3231

(3018010) Neutrophils/100 leukocytes in Blood

2397

18317

1.57

53.22

4.7

5.6

60.84

58.11

19.21

2237

16880

(3018418) pH of Serum or Plasma

1695

11983

1.61

52.36

5.1

3.4

7.40

0.15

342

2074

(40760892) CBC W Ordered Manual Differential panel - Blood

2359

18062

1.55

51.26

5.1

5.8

—

(3025941) Bacteria identified in Stool by Culture

429

1998

2.25

50.07

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

250

902

2.86

50.02

3.4

1.5

37.62

22.70

u/ml

2.03

243

850

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1087

7008

1.69

47.59

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2090

15801

1.53

46.73

2.6

2.9

154.02

142.13

ug/l

0.56

1926

14349

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

375

1702

2.29

46.47

2.0

1.8

2.31

1.76

ug/l

0.49

336

1465

(3001604) Monocytes [#/volume] in Blood

2471

19460

1.51

44.97

4.7

5.3

0.61

0.62

e9/l

0.16

2063

16642

(3006315) Basophils [#/volume] in Blood

2478

19529

1.51

44.93

4.7

5.3

0.04

e9/l

12.67

2074

16707

(3019198) Lymphocytes [#/volume] in Blood

2516

19980

1.50

43.39

4.8

5.4

1.67

1.83

e9/l

1.53

2163

17435

(3039000) Anion gap in Blood

247

959

2.65

42.90

8.9

6.9

10.92

11.38

mmol/l

1.76

225

860

(3018572) Chloride [Moles/volume] in Blood

247

959

2.65

42.90

8.9

6.9

106.68

104.80

mmol/l

9.77

225

860

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

289

1214

2.46

42.61

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

11.37

42.21

1.3

1.1

—

(3013115) Eosinophils [#/volume] in Blood

2529

20212

1.48

41.58

4.9

5.5

0.18

0.21

e9/l

10.44

2161

17490

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

713

4248

1.78

40.80

4.8

3.3

—

(3047181) Lactate [Moles/volume] in Blood

313

1390

2.33

40.73

7.8

6.0

1.35

1.33

mmol/l

0.19

278

1235

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

386

1913

2.10

38.26

6.7

4.9

1.59

1.64

0.43

359

1795

(40768795) Lymph node Pathology biopsy report

8.26

38.04

1.2

1.1

—

(3021589) Normoblasts [#/volume] in Blood

2197

17278

1.47

38.02

15.6

8.7

0.00

e9/l

0.35

1782

14122

(3008152) Bicarbonate [Moles/volume] in Arterial blood

532

2968

1.88

37.54

8.5

7.2

24.65

24.56

mmol/l

0.24

509

2838

(3007930) Methemoglobin/Hemoglobin.total in Blood

379

1888

2.08

37.04

6.9

4.9

0.90

0.88

0.70

353

1773

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4277

38475

1.59

36.64

29.4

12.9

78.26

75.30

ml/min/173m2

18.78

3810

31140

(3003458) Phosphate [Moles/volume] in Serum or Plasma

828

5316

1.66

35.77

4.6

5.6

1.02

1.03

mmol/l

0.82

777

4859

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

469

2602

1.88

33.54

1.7

1.6

—

(40768441) Liver Pathology biopsy report

139

4.94

31.35

1.1

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

662

4144

1.68

31.21

3.1

2.7

255.61

238.69

u/l

1.13

634

3810

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

216

918

2.41

31.01

2.1

2.4

3.71

3.59

g/l

0.52

208

867

(3019060) Gas panel - Arterial blood

530

3135

1.77

30.64

6.5

4.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

142

493

2.93

30.51

1.2

1.3

—

(3051651) Icteric interference index of Serum or Plasma

201

4.13

30.17

5.1

4.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

968

6701

1.54

29.98

2.0

1.9

29.98

30.09

0.23

949

6492

(40768793) Breast Pathology biopsy report

157

4.57

29.81

1.4

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

243

1142

2.18

27.55

1.9

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

721

4798

1.58

26.29

1.8

—

(3044889) 12 lead EKG panel

3404

29979

1.38

26.26

4.4

4.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3470

30660

1.38

26.22

3.5

4.1

16.39

12.53

mm/h

27.95

3185

28079

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

735

4920

1.57

26.11

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4634

43256

1.59

25.66

34.2

17.0

139.27

139.79

mmol/l

37.93

4579

42028

(3023103) Potassium [Moles/volume] in Serum or Plasma

4639

43364

1.58

24.94

34.3

17.1

3.95

4.00

mmol/l

42.12

4582

42071

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

727

4932

1.55

24.22

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

420

2512

1.73

23.17

1.4

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

644

4300

1.57

22.95

3.1

3.7

5.73

5.84

kpa

2.29

622

4169

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

193

3.71

22.71

1.2

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

184

837

2.24

22.63

1.4

1.3

—

(3002032) Base excess in Venous blood by calculation

638

4283

1.56

22.16

3.2

3.7

1.92

1.95

mmol/l

0.07

529

3639

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2841

24779

1.32

20.75

3.6

3.0

62.73

49.91

u/l

6.97

2674

22531

(3049717) Cytology report of Urine Cyto stain

267

1465

1.87

19.65

2.6

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

709

5027

1.47

18.82

2.2

2.1

1.74

1.75

0.07

628

4344

(40761511) CBC panel - Blood by Automated count

4471

41960

1.43

18.62

27.6

13.6

—

(3002385) Erythrocyte distribution width [Ratio]

3751

34252

1.33

18.51

37.0

16.1

15.59

15.30

2.50

3720

33506

(3051611) Lipemic interference index of Serum or Plasma

106

414

2.59

18.33

4.6

3.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

126

536

2.38

18.17

5.9

6.4

12.39

12.02

mg/l

0.33

110

483

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

338

2039

1.70

18.02

3.0

4.1

24.10

24.15

mmol/l

0.10

330

1988

(3013512) EKG study

1614

13257

1.31

17.26

4.2

4.3

—

(40762365) Oxygen content in Arterial blood by calculation

5.44

17.10

4.5

2.3

13.81

15.25

ml/dl

1.86

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4598

43514

1.44

16.96

18.4

9.4

24.22

25.83

u/l

10.30

4512

41497

(4281824) Cell count and differential, peritoneal fluid

183

3.36

16.91

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

493

3317

1.54

16.78

4.6

3.1

1.22

1.23

mmol/l

0.90

442

2793

(3025468) Yersinia sp identified in Specimen by Organism specific culture

112

470

2.41

16.68

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

113

478

2.39

16.54

1.4

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

176

894

2.00

16.33

2.3

2.4

213.66

195.56

1.94

168

845

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

111

469

2.40

16.29

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

111

472

2.38

16.07

1.4

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

111

476

2.36

15.77

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

113

491

2.33

15.59

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3850

41080

0.77

15.35

4.2

4.9

4.52

4.50

mmol/l

0.61

3495

37748

(3021601) Nitrite [Presence] in Urine by Test strip

2294

19952

1.26

15.05

5.6

4.9

0.00

estimate

0.50

501

3388

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3816

40734

0.77

14.99

4.2

4.8

1.44

1.43

mmol/l

0.68

3443

37176

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

432

6276

0.66

14.95

1.2

11.21

14.60

u/ml

0.43

159

2332

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

452

3067

1.52

14.75

1.3

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

279

1689

1.69

14.70

4.6

4.3

1.31

1.42

mmol/l

0.69

270

1656

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

465

6636

0.67

14.69

1.2

1.3

48.92

38.29

iu/ml

0.48

142

2053

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

14.59

1.1

0.0

—

(3052851) Hemolysis interference index of Serum or Plasma

214

1208

1.80

14.43

4.8

3.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

372

2438

1.57

14.22

2.3

2.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

511

3584

1.47

14.17

2.9

3.1

4.59

4.49

kpa

0.42

491

3460

(3019225) pH of Specimen

591

4262

1.44

14.15

4.3

3.7

—

(3012501) Base excess in Blood by calculation

175

933

1.91

14.14

4.5

4.2

2.66

2.62

mmol/l

0.06

128

615

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

284

1750

1.66

13.99

2.0

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

2306

20192

1.25

13.87

4.2

3.7

0.00

estimate

1.34

495

3237

(3014765) Yersinia sp identified in Stool by Organism specific culture

201

1128

1.81

13.83

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

199

1117

1.81

13.68

1.2

—

(40761536) Microorganisms panel - Urine sediment

452

3116

1.49

13.66

4.8

4.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

201

1136

1.80

13.52

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3981

42091

0.78

12.96

4.7

5.5

2.63

2.62

mmol/l

0.24

3576

38510

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

183

3.03

12.94

2.4

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

2279

20035

1.24

12.89

4.2

3.7

0.00

estimate

2.14

525

3691

(3010421) pH of Blood

193

1103

1.78

12.53

4.3

4.2

7.43

7.42

1.34

178

977

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

260

1617

1.64

12.38

1.9

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

159

862

1.87

12.26

2.3

2.6

34.08

34.76

umol/l

0.12

144

764

(3020891) Body temperature

297

1914

1.58

12.22

5.2

5.1

—

(3023520) Reticulocytes [#/volume] in Blood

520

3764

1.42

12.15

2.3

2.1

66.73

68.45

e9/l

0.53

383

2866

(3004809) Band form neutrophils/100 leukocytes in Blood

103

486

2.14

11.75

2.8

2.9

3.18

1.33

2.94

411

(3036489) Thrombin time

218

1314

1.69

11.72

2.0

1.9

21.38

21.32

0.06

206

1152

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3713

39452

0.80

11.60

3.8

4.3

1.29

1.30

mmol/l

0.05

3314

35665

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3728

39589

0.80

11.55

6.0

6.5

40.84

40.89

mmol/mol

0.09

3380

36339

(1616796) Gas panel - Central venous blood

166

936

1.80

11.31

3.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

417

2942

1.45

11.19

1.3

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

159

2.97

10.80

1.9

2.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

8.24

10.78

7.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

411

2.18

10.75

1.5

1.4

202.84

71.25

pmol/l

0.96

396

(3009542) Hematocrit [Volume Fraction] of Blood

4668

44890

1.35

10.42

44.0

20.5

38.07

40.38

51.18

4415

41230

(3017181) Myelocytes/100 leukocytes in Blood

432

3109

1.42

10.41

3.2

3.7

1.01

0.78

1.34

183

821

(3003327) Ova and parasites identified in Stool by Light microscopy

181

1079

1.70

10.19

1.6

1.7

—

(3045142) Bone marrow Pathology biopsy report

287

2.39

10.16

1.3

1.2

—

(3024731) MCV [Entitic volume]

4669

44931

1.34

10.12

43.5

20.3

91.37

91.55

1.81

4622

44029

(3000963) Hemoglobin [Mass/volume] in Blood

4670

44943

1.34

10.12

44.0

20.5

126.99

136.55

g/l

292.97

4623

44053

(3035941) MCH [Entitic mass]

4669

44933

1.34

10.10

43.5

20.3

30.18

30.49

24.14

4621

44033

(3010813) Leukocytes [#/volume] in Blood

4669

44934

1.34

10.09

43.6

20.4

6.73

6.78

e9/l

0.76

4564

43276

(3026361) Erythrocytes [#/volume] in Blood

4669

44937

1.34

10.07

43.6

20.4

4.27

4.50

e12/l

166.80

4563

43281

(3007461) Platelets [#/volume] in Blood

4667

44921

1.34

10.01

43.7

20.4

248.08

240.82

e9/l

9.85

4570

43453

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

465

3414

1.40

9.99

4.1

2.4

63.25

62.86

ml/min/173m2

0.07

194

1298

(3021440) Promyelocytes/100 leukocytes in Blood

415

2993

1.42

9.88

3.2

3.7

0.18

0.08

1.99

168

706

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

150

860

1.77

9.71

1.7

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

499

2.00

9.55

1.4

1.5

30.63

28.68

g/l

0.74

435

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

939

7685

1.27

9.43

1.2

1.28

2.03

u/ml

1.63

252

2002

(3043410) Blood group antigens tested for on Red Blood Cells

3.38

9.15

2.6

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

263

1772

1.51

8.92

1.2

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

803

6504

1.28

8.73

1.4

1.3

2.57

2.67

g/l

0.56

447

3678

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1665

14597

1.21

8.64

2.7

3.2

1368.11

1586.28

ng/l

1.71

1471

12595

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

297

2073

1.46

8.46

1.6

1.5

1.74

1.54

g/l

2.91

257

1756

(3037522) Nuclear Ab [Titer] in Serum

380

5122

0.72

8.45

1.3

542.94

520.99

titre

0.07

1105

(3002179) Metamyelocytes/100 leukocytes in Blood

389

2853

1.39

8.42

3.1

3.5

0.69

0.59

0.57

158

722

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

8.33

1.0

0.0

—

(3025159) Blasts/100 leukocytes in Blood

389

2862

1.39

8.26

3.2

3.8

0.43

0.08

0.46

143

593

(3004716) Salmonella sp identified in Stool by Organism specific culture

231

1542

1.52

8.21

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

963

11447

0.81

8.20

1.6

1.7

1.44

1.35

mmol/l

1.19

795

9453

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

245

1659

1.50

8.14

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

377

2.06

8.11

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

150

907

1.67

8.09

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

150

907

1.67

8.09

1.3

—

(40768806) Pleura Pathology biopsy report

344

2.11

8.08

1.4

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

142

849

1.69

7.99

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

372

2735

1.39

7.94

3.1

3.5

2.06

1.82

mmol/l

0.55

266

1989

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1062

8970

1.23

7.93

3.4

4.2

793.99

545.60

ng/l

0.58

888

7579

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

136

819

1.68

7.48

1.4

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2832

30398

0.85

7.47

3.4

3.7

15.05

14.96

pmol/l

0.95

2495

27151

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

384

2872

1.36

7.39

3.0

3.5

5.06

5.16

kpa

1.39

357

2693

(40767503) Oxygen content in Capillary blood by calculation

146

899

1.64

7.37

2.9

2.5

15.45

16.38

1.51

482

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

105

592

1.79

7.30

1.5

—

(3009343) pH of Capillary blood

378

2829

1.36

7.24

3.1

3.5

7.43

7.42

0.34

339

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

185

2.44

7.23

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

185

2.44

7.23

1.3

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

391

2945

1.35

7.19

2.8

3.3

123.04

130.27

g/l

8.09

380

2869

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

473

1.87

7.14

1.1

1.62

1.53

g/l

1.19

420

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

553

1.79

6.82

2.5

5.5

899.70

878.90

iu/ml

—

(3045414) Leukocytes [Presence] in Urine

259

1838

1.43

6.81

2.1

1.9

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

324

2.02

6.59

1.3

1280.67

283.53

u/l

0.48

304

(3000012) Reticulocyte production index

103

596

1.74

6.59

2.2

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

252

2.15

6.51

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

259

2.13

6.49

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

151

969

1.57

6.48

3.2

2.8

7.92

7.85

kpa

0.20

146

941

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.01

6.48

1.3

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

471

3704

1.30

6.42

1.3

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

111

662

1.69

6.39

4.1

3.5

59.33

58.97

0.09

111

662

(3023199) Leukocytes [#/volume] in Pleural fluid

450

1.83

6.28

1.4

1.5

842.38

2972.04

e6/l

2.60

335

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

156

2.45

6.17

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

156

2.45

6.17

1.3

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

403

1.87

6.15

1.4

1.5

22559.38

66466.78

e6/l

1.28

241

(3027273) Bicarbonate [Moles/volume] in Venous blood

320

2403

1.35

6.04

3.3

3.2

24.71

25.22

mmol/l

1.45

305

2321

(3021901) Oxygen saturation in Capillary blood

131

830

1.59

5.97

3.2

2.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

169

1136

1.50

5.92

1.3

1.4

254.24

289.70

ug/g

1.41

102

697

(3001893) Eosinophils/100 leukocytes in Pleural fluid

112

2.69

5.90

1.5

0.91

2.19

1.33

(3022806) Fractional oxyhemoglobin in Capillary blood

534

1.74

5.87

1.9

1.8

89.21

89.42

0.12

527

(3041096) Erythrocytes [Presence] in Urine by Automated

1156

10106

1.18

5.80

4.6

3.4

—

(3015736) pH of Urine

1781

16116

1.16

5.78

3.7

3.5

5.81

5.79

0.07

794

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

125

790

1.60

5.77

1.3

1.6

—

(3024928) Oxygen saturation in Venous blood

146

958

1.54

5.73

1.8

3.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1949

17763

1.15

5.72

3.7

4.0

61.66

75.71

ng/l

0.20

1552

13209

(1002224) Polysomnography panel

1316

0.58

5.45

1.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

154

2.35

5.39

1.6

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1223

10808

1.17

5.33

1.6

20.03

20.25

nmol/l

0.19

1046

9091

(3024891) Influenza virus A+B Ag [Presence] in Specimen

135

889

1.53

5.25

1.1

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

228

2.07

5.21

1.7

1.9

2.51

1.89

u/field

0.30

150

(3045788) Cell count panel - Pleural fluid

347

1.85

5.17

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1129

9955

1.17

5.03

3.4

3.7

—

(3033799) Differential panel - Peritoneal fluid

2.70

4.99

2.6

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

1242

11039

1.16

4.99

4.5

4.1

0.01

0.00

estimate

0.30

448

3266

(3020682) Albumin/Creatinine [Ratio] in Urine

1420

15732

0.87

4.97

4.0

3.9

12.01

8.66

mg/mmol

0.86

930

10054

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

388

1.79

4.97

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

111

2.53

4.94

1.6

1.5

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

6.88

4.94

1.1

1.2

1.00

1.18

u/field

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

154

2.28

4.94

1.6

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3954

40929

0.86

4.91

4.5

5.0

6.13

6.09

mmol/l

0.97

3538

36904

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

112

2.51

4.86

1.6

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

112

2.51

4.86

1.6

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

297

1.89

4.86

1.6

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

202

2.09

4.79

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

202

2.09

4.79

1.5

1.4

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

11.44

4.78

1.3

1.9

163.25

180.86

umol/l

—

(4200892) Spirometry reversibility

247

3239

0.75

4.62

1.3

1.4

—

(4034850) Laboratory test

102

1561

0.65

4.60

12.4

10.2

—

(3014051) Protein [Presence] in Urine by Test strip

158

1107

1.44

4.57

2.7

2.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

240

1.97

4.57

1.3

14.15

11.75

u/l

0.17

213

(3045424) Erythrocytes [Presence] in Urine

103

660

1.57

4.57

1.7

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.72

4.50

1.3

1.2

740.38

4.93

ug/l

0.56

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

3.27

4.46

2.2

1.1

1.53

2.87

ug/l

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.62

4.38

1.3

1.9

10.96

13.62

g/l

0.96

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

112

2.42

4.37

6.3

1.1

57.09

103.99

u/ml

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

405

1.71

4.34

1.1

—

(3022313) Gas panel - Capillary blood

269

2078

1.31

4.27

2.9

3.6

—

(3017732) Neutrophils [#/volume] in Blood

331

2641

1.27

4.10

4.5

3.0

4.23

5.42

e9/l

2.81

272

1964

(3017354) Segmented neutrophils/100 leukocytes in Blood

330

1.77

4.08

2.4

2.8

58.25

59.57

0.17

267

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

561

1.58

4.04

1.3

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

561

1.58

4.04

1.3

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1353

14866

0.88

4.02

3.3

3.2

319.44

284.41

mg/l

0.12

920

9642

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

238

1.90

4.00

1.5

1.3

—

(3000494) Fungus identified in Specimen by Culture

549

4643

1.20

3.95

1.6

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

1381

15130

0.88

3.90

3.3

3.2

7.56

7.53

mmol/l

0.12

1115

12628

(4094501) Cardiovascular stress test using bicycle ergometer

1275

0.65

3.87

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

173

2322

0.74

3.84

1.2

1.3

104.91

57.00

au/ml

—

125

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

390

1.67

3.82

2.7

3.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

114

2.29

3.77

3.3

2.7

—

(1761868) Lipid panel - Serum or Plasma

1164

12868

0.88

3.76

3.0

3.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

339

1.72

3.75

3.2

—

(3011648) Oxygen content in Venous blood

332

1.72

3.73

1.2

2.2

11.26

11.06

0.13

332

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

230

1775

1.31

3.72

2.9

3.8

24.76

24.86

mmol/l

0.17

205

1611

(3009466) Valproate [Moles/volume] in Serum or Plasma

599

0.50

3.70

3.9

4.5

330.05

352.83

umol/l

0.36

504

(3002619) Bacteria identified in Specimen by Culture

2.69

3.65

1.3

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1315

14398

0.88

3.63

2.1

2.2

211.88

231.26

u/l

0.31

1241

13401

(21494755) Public health laboratory ask at order entry panel

164

2196

0.74

3.60

1.3

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

285

1.76

3.55

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.45

3.54

2.1

2.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

516

1.56

3.54

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

141

1018

1.40

3.54

2.7

2.1

123.10

131.14

g/l

3.14

106

751

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

138

2.11

3.48

1.4

56.74

64.05

0.38

112

(1761482) Bacteria [#/volume] in Urine by Culture

166

1237

1.35

3.44

5.2

3.9

—

(3008898) HLA-B27 [Presence]

948

0.62

3.41

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

967

8660

1.14

3.39

1.7

2.01

1.25

mg/l

4.58

791

6696

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.08

3.39

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

367

1.64

3.32

1.7

2.1

2.69

1.83

u/field

0.56

133

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

336

4065

0.81

3.29

1.4

1.5

—

(3019977) pH of Arterial blood

255

1.77

3.28

2.9

2.2

7.42

7.43

0.15

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

583

1.50

3.26

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1130

0.66

3.25

1.2

1.7

2.98

4.19

mg/l

0.79

839

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.03

3.24

3.9

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

234

1.80

3.24

2.9

1.5

139.53

1927.06

u/l

0.91

(3044242) Glucose [Moles/volume] in Arterial blood

234

1.80

3.24

2.2

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

200

2563

0.77

3.24

2.3

2.4

48.27

21.83

au/ml

—

133

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

301

1.70

3.23

1.4

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

301

1.70

3.23

1.4

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

301

1.70

3.23

1.4

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

286

1.72

3.23

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

116

2.16

3.21

1.8

2.7

738.67

564.97

e6/l

0.24

(3007566) Smooth muscle Ab [Titer] in Serum

133

970

1.38

3.18

1.1

1.2

134.29

118.80

titre

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

661

1.46

3.16

1.3

1.4

—

(3000330) Specific gravity of Urine by Test strip

287

2335

1.24

3.08

5.3

3.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.80

3.08

1.7

2.1

—

(3017569) Oxygen content in Arterial blood

239

1.76

3.04

2.2

1.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

315

1.66

3.02

1.3

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

371

4400

0.83

2.98

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

506

1.51

2.97

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

141

1869

0.75

2.95

1.2

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3651

37618

0.90

2.89

4.1

4.5

2.03

2.05

mu/l

0.26

3232

33853

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2030

19111

1.10

2.89

2.1

87.32

93.71

pmol/l

8.08

1188

9899

(3026493) Urate [Moles/volume] in Serum or Plasma

1066

11676

0.89

2.88

2.6

2.5

4773.24

5771.84

umol/l

0.32

910

10014

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

108

1484

0.72

2.87

1.3

1.6

—

(36660697) Celiac disease serology panel - Serum

335

2793

1.21

2.86

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1326

0.71

2.79

1.2

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.58

2.78

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

517

1.48

2.71

1.8

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

271

1.67

2.70

2.4

2.7

—

(3011544) Albumin [Mass/volume] in Pleural fluid

3.45

2.68

1.1

19.79

13.72

g/l

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

561

1.45

2.65

1.1

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

120

1597

0.75

2.62

1.5

—

(40765096) Chromosome analysis panel by Banding

2.55

2.61

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1205

0.71

2.60

1.5

18021.86

14025.85

e6/l

0.18

881

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.67

2.59

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

126

946

1.34

2.58

2.4

2.7

1.74

mg/l

0.01

114

827

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1337

0.73

2.53

1.3

1.4

—

(3035880) pH of Pleural fluid

208

1.74

2.53

1.2

1.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.50

2.52

1.6

1.4

26.00

5.85

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

109

1461

0.74

2.51

1.2

4.68

0.68

u/ml

0.79

150

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

113

840

1.35

2.48

1.5

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

225

1.69

2.46

1.6

1.5

9.29

7.81

u/l

0.20

185

(3040151) Glucose [Moles/volume] in Capillary blood

513

1.45

2.43

6.9

21.6

6.69

7.58

mmol/l

2.77

420

(3036481) Cortisol [Moles/volume] in Serum or Plasma

366

3133

1.18

2.39

1.9

1.8

405.34

365.66

nmol/l

3.45

340

2802

(3005322) IgE [Units/volume] in Serum or Plasma

178

2215

0.80

2.34

1.2

1.3

219.01

234.48

u/ml

0.11

155

2041

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

865

0.68

2.33

1.3

1.4

3042.29

1086.40

e6/l

0.32

721

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.31

2.1

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

863

0.68

2.31

1.2

1.3

7.00

27.47

e6/l

1.55

678

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

528

1.43

2.29

1.3

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

203

0.39

2.27

1.1

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

538

6057

0.88

2.27

11.0

7.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

4.62

2.27

1.3

2.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.02

2.25

2.0

2.6

22819.33

23898.80

e6/l

0.01

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.56

2.21

1.0

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

150

1.80

2.19

1.4

2.1

14.59

17.15

0.60

144

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

143

1.82

2.18

1.4

2.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1151

0.73

2.14

1.4

1.8

40.76

43.43

nmol/l

0.73

1098

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

167

0.36

2.13

1.2

1.9

19.80

224.60

ug/l

—

157

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

939

0.71

2.10

1.2

3.38

5.23

u/ml

0.61

153

(3019832) Treponema pallidum Ab [Presence] in Serum

1213

0.75

2.08

1.3

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

109

833

1.31

2.04

1.2

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

758

0.68

2.03

1.3

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

155

1.75

1.99

1.4

2.1

71.19

72.34

0.12

144

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

929

0.72

1.99

1.2

8.66

9.59

u/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

859

0.71

1.98

1.2

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

202

1671

1.22

1.97

2.2

2.3

495.77

626.40

ug/l

0.34

195

1579

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.34

1.96

1.1

1.9

—

(3036603) Volume of Urine

233

1.59

1.95

1.8

1.4

1931.41

1876.82

0.17

222

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.55

1.94

1.4

1.5

0.24

5.73

mg/l

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

127

1.81

1.93

1.6

2.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

485

0.62

1.92

1.3

83191.22

208383.00

e6/l

0.93

333

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2044

19516

1.08

1.89

4.7

3.9

2.70

2.06

ug/l

3.16

1779

17464

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.18

1.88

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

158

0.38

1.87

1.2

1.1

220.67

248.31

iu/ml

—

153

(3044290) Cell count panel - Cerebral spinal fluid

765

0.70

1.84

1.2

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.17

1.82

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

160

1950

0.81

1.81

1.2

158.42

126.10

iu/ml

0.38

730

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

101

1.88

1.80

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

853

0.72

1.78

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

337

0.56

1.76

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

329

1.46

1.76

1.8

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

603

0.68

1.73

1.4

1.5

63.86

61.39

0.13

396

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.92

1.72

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

864

9317

0.91

1.70

4.3

4.2

1.02

kg/l

0.17

144

1378

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

395

0.61

1.69

1.1

—

1.40

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1147

0.77

1.66

1.5

1.6

0.73

2.90

iu/ml

0.44

260

(3003338) MCHC [Mass/volume]

3440

33551

1.07

1.65

38.7

18.4

329.83

332.47

g/l

52.59

3413

33241

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

491

4420

1.12

1.65

2.4

3.1

226.58

234.58

ng/l

0.15

444

4059

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

315

0.57

1.61

1.2

1.4

202.92

198.89

pmol/l

0.04

315

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

575

1.33

1.60

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

533

0.67

1.59

1.4

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

2.50

1.59

1.1

1.0

—

(3022621) pH of Urine by Test strip

323

2838

1.15

1.59

3.1

3.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.07

1.59

1.0

1.2

68.86

145.83

ng/l

—

(3037756) Immunofixation for Serum or Plasma

106

840

1.27

1.58

1.6

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

263

1.49

1.57

1.9

2.1

58.89

231.26

ug/min

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1216

0.79

1.57

1.4

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

114

912

1.26

1.57

1.0

1.1

1.39

9.41

u/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

405

3616

1.13

1.57

2.6

1.6

64.67

66.71

g/l

5.47

367

3195

(3000093) Morphology [Interpretation] in Blood Narrative

397

1.39

1.56

1.1

—

(3024263) Appearance of Synovial fluid

260

0.54

1.55

1.0

1.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

1.52

0.0

1.1

—

79.07

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1053

0.78

1.51

1.6

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

244

0.53

1.50

1.4

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.86

1.50

1.3

1.4

15.60

29.35

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

126

0.40

1.49

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

131

1.68

1.49

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

429

0.65

1.48

1.4

1.7

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.95

1.48

1.3

2.0

17.57

8.82

0.72

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

139

1.66

1.48

3.7

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

139

1.66

1.48

3.7

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

167

0.48

1.46

1.1

—

9.65

u/ml

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

451

0.66

1.46

1.4

1.5

33.49

28.29

0.28

298

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1617

15431

1.07

1.45

4.7

4.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

378

0.63

1.45

1.1

—

26.04

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.12

1.44

1.3

1.8

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.13

1.44

1.0

1.1

189.20

253.00

nmol/l

—

(3046861) Legionella sp Ag [Presence] in Urine

3.13

1.44

1.0

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.92

1.43

1.3

1.9

34.14

27.09

0.68

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

107

1321

0.81

1.43

2.7

2.2

170.61

112.26

ug/min

0.45

780

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.77

1.38

1.2

1.5

—

(3042631) Mycobacterium sp identified in Specimen

546

1.30

1.37

1.9

3.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

356

1.38

1.37

1.8

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

289

1.42

1.36

1.5

1.7

91.12

91.36

umol/l

0.01

289

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2118

20422

1.06

1.36

2.3

2.4

—

(3004616) Nuclear Ab [Presence] in Serum

490

0.69

1.35

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

651

0.73

1.33

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

128

1.64

1.32

2.7

2.5

33.09

43.28

1.71

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.78

1.32

1.3

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.09

1.30

1.0

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

395

1.34

1.28

1.0

1.1

3.18

3.24

u/ml

0.02

151

(3047189) Immunofixation for 24 hour Urine

161

1.56

1.28

1.6

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

131

0.46

1.28

41.2

33.3

6.20

7.42

ug/l

—

121

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.00

1.27

2.1

2.8

0.82

0.38

u/field

0.55

(3025130) Human papilloma virus identified in Specimen

227

1.46

1.26

1.5

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

328

0.64

1.25

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

305

2722

1.13

1.24

1.9

2.2

11.39

14.66

nmol/l

8.45

259

2380

(3014891) Appearance of Pleural fluid

1.91

1.22

1.7

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

539

1.28

1.22

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1723

16558

1.06

1.21

2.2

75.72

78.62

nmol/l

3.76

1505

14424

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.16

1.21

12.6

9.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

455

0.70

1.21

1.1

—

(3003181) Sodium [Moles/volume] in Urine

772

1.23

1.21

1.4

1.3

61.55

62.97

mmol/l

0.12

612

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

702

1.24

1.18

2.9

3.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

522

5655

0.91

1.18

4.4

5.0

32.95

32.80

0.12

334

3796

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

1.16

0.0

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

102

1.67

1.16

2.6

2.2

7.81

8.07

mmol/l

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

190

1.48

1.16

1.1

5.9

48.22

77.37

mg/l

1.84

126

(3028717) Thiamine [Mass/volume] in Blood

2.05

1.15

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

2.50

1.15

1.4

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

351

1.34

1.15

1.1

—

(4062490) Immunoglobulin typing, IgG

402

0.69

1.13

1.3

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

216

1.44

1.13

1.3

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

1.65

1.12

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

111

1.62

1.11

1.7

1.4

13.78

17.13

pmol/l

1.32

(3006922) Hepatitis E virus Ab [Presence] in Serum

209

1.44

1.10

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.38

1.09

3.2

2.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.95

1.08

1.0

1.1

—

(4212803) Bone marrow aspirate examination

2.19

1.08

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

165

1431

1.16

1.06

2.8

1.5

34.78

34.58

mg/l

0.02

136

1152

(3014148) Varicella zoster virus Ab [Titer] in Serum

290

0.65

1.06

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

278

0.65

1.06

1.8

1.7

—

(3023419) Bacteria identified in Sputum by Culture

725

0.78

1.05

1.9

2.5

—

(3013637) Mi-2 Ab [Presence] in Serum

123

0.49

1.05

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

123

0.49

1.05

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

123

0.49

1.05

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

123

0.49

1.05

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.79

1.04

1.5

2.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

162

1.48

1.03

1.6

2.3

92.13

92.63

0.02

150

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

517

1.26

1.03

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

571

1.25

1.03

1.6

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.73

1.02

1.0

1.2

—

(3014271) Vancomycin [Susceptibility]

281

1.35

1.01

2.8

3.0

—

(4146454) Self-monitoring of blood glucose

565

1.24

0.99

3.2

2.8

—

(3000492) Spirometry study

333

3649

0.91

0.99

1.4

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

402

0.72

0.99

1.3

1.4

0.33

0.42

g/l

0.91

286

(3028192) IgG subclass 2 [Mass/volume] in Serum

402

0.72

0.99

1.3

1.4

2.36

2.99

g/l

1.38

284

(3027135) IgG subclass 1 [Mass/volume] in Serum

402

0.72

0.99

1.3

1.4

5.91

6.89

g/l

0.78

284

(3028707) Methadone [Presence] in Urine by Screen method

237

0.63

0.98

1.3

2.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

485

1.26

0.98

2.5

2.1

0.89

1.49

g/24h

1.69

221

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

134

0.52

0.98

1.1

722.86

1675.38

miu/ml

—

134

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

223

2496

0.89

0.98

1.7

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

240

1.38

0.98

2.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

198

1.42

0.97

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

198

1.42

0.97

1.0

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.6

—

0.74

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

164

1435

1.15

0.96

2.8

1.5

53.98

47.17

mg/l

0.67

136

1162

(40760888) Immunoglobulin light chains.free panel - Serum

123

1054

1.17

0.95

2.3

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

216

1.39

0.95

1.3

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

278

2516

1.11

0.94

2.9

2.2

9.78

10.83

g/l

4.16

256

2291

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

159

1390

1.15

0.94

2.8

1.5

1.40

2.42

ratio

—

119

(3023410) Appearance of Cerebral spinal fluid

350

0.71

0.92

1.3

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

410

1.27

0.91

1.2

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

410

1.27

0.91

1.2

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

1.67

0.91

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

168

1.43

0.89

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.07

0.89

1.0

1.2

—

13.64

—

(3009871) Measles virus Ab [Titer] in Serum

105

0.48

0.88

1.8

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

101

1183

0.85

0.87

1.5

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

272

1.33

0.87

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

352

1.28

0.85

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

614

0.80

0.85

1.3

1.6

1.00

0.87

g/l

0.19

466

(21494814) CD8 cells/100 lymphocytes in Specimen

1.63

0.84

1.5

2.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

898

0.83

0.84

1.4

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

154

1.43

0.83

1.9

1.3

29.21

9.24

umol/l

0.52

100

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

257

1.32

0.82

1.1

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

376

0.74

0.82

1.1

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.70

0.80

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

172

1.40

0.80

1.1

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.79

0.0

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

163

0.61

0.78

1.1

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

163

0.61

0.78

1.1

1.3

48.27

57.84

—

143

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.77

0.0

1.3

—

(3021788) Differential panel - Synovial fluid

867

0.84

0.77

1.4

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

612

1.20

0.76

3.2

2.2

—

(3006653) Thiamine [Moles/volume] in Blood

198

0.66

0.76

1.1

1.2

131.95

139.73

nmol/l

0.26

198

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.77

0.76

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

149

1.41

0.75

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

778

0.83

0.75

1.8

1.7

7.12

4.70

iu/l

0.42

244

(3010838) Calcium [Moles/time] in 24 hour Urine

658

0.82

0.75

1.6

2.0

4.52

4.88

mmol/24h

0.32

558

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

100

1.50

0.72

1.1

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

553

1.20

0.71

1.5

2.3

59.27

25.86

mg/l

1.14

133

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.92

0.70

2.4

2.2

—

(3051593) INR in Capillary blood by Coagulation assay

247

1.30

0.70

16.9

9.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

432

0.79

0.69

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1127

10870

1.05

0.69

3.1

2.8

0.81

0.72

ug/l

1.32

796

7512

(3052592) Norovirus Ag [Presence] in Stool

1.51

0.69

1.6

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

181

0.66

0.69

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

146

1631

0.89

0.69

1.7

1.8

39.27

38.31

u/l

0.21

129

1376

(3016228) CD19 cells/100 cells in Blood

1.53

0.68

1.5

2.3

6.38

7.94

0.34

(3023420) DNA double strand Ab [Units/volume] in Serum

364

0.77

0.68

1.1

1.4

—

25.37

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

119

0.59

0.67

1.1

1.4

9.98

9.30

ug/l

—

119

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

452

0.79

0.67

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

168

0.65

0.67

1.4

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

121

0.58

0.67

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.79

0.66

1.4

1.2

—

(3022689) Creatine [Moles/volume] in Urine

155

0.64

0.65

1.2

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

189

1.32

0.64

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

773

0.85

0.63

1.2

5.87

5.59

u/ml

—

(3044941) Cell count panel - Synovial fluid

762

0.85

0.62

1.4

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

217

1.29

0.61

2.1

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

489

1.19

0.61

1.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

139

1543

0.90

0.61

1.5

1.6

216.67

306.47

titre

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.48

0.60

1.4

1.3

—

(3020650) Glucose [Presence] in Urine

1.48

0.60

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

218

1.29

0.59

1.5

1.3

45.46

34.29

u/l

0.62

145

(3038026) Centromere Ab [Units/volume] in Serum

333

0.78

0.59

1.1

1.2

—

74.03

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

896

0.87

0.59

1.3

1.5

1.06

0.82

nmol/l

0.92

736

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.53

0.59

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

174

0.69

0.59

1.1

0.95

1.06

u/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.51

0.58

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.71

0.57

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

419

1.19

0.57

2.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

132

1.36

0.57

1.1

1.2

—

(3048879) Bone marrow aspiration report

1.43

0.56

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

274

0.77

0.55

1.1

3.89

2.44

u/ml

—

128

(3002079) Sodium [Moles/time] in 24 hour Urine

183

0.71

0.55

1.2

164.31

175.68

mmol/24h

0.09

183

(3028433) Virus identified in Specimen by Culture

122

0.66

0.54

1.4

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

598

1.16

0.54

1.3

38.14

32.60

iu/l

0.65

519

(3034426) Prothrombin time (PT)

125

0.64

0.54

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

525

0.84

0.54

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

216

0.74

0.53

1.2

1.1

0.43

0.44

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

694

1.14

0.52

1.1

1.2

—

(3024471) HLA-A [Type]

0.61

0.52

1.0

—

(21494434) Karyotype in Bone marrow

314

1.21

0.51

1.2

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

161

1.31

0.51

2.4

2.7

49242.86

39567.70

ug/l

1.85

161

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

301

0.80

0.48

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

190

1.26

0.47

1.5

1.3

0.53

0.23

nmol/l

0.58

147

(3006462) Nitrate [Presence] in Urine

190

1.26

0.47

4.0

3.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

153

1406

1.09

0.47

2.0

3.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

214

1995

1.08

0.47

2.1

1.4

1.54

1.14

g/l

1.35

198

1805

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

739

0.88

0.46

1.2

121.45

23.55

u/l

0.97

633

(3016650) Hepatitis A virus Ab [Presence] in Serum

495

1.15

0.46

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.43

0.46

1.7

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.61

0.45

1.4

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

255

1.22

0.45

1.1

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1001

0.90

0.45

1.8

1.9

10.51

11.68

mg/l

0.85

920

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

286

0.80

0.44

1.1

1.2

2.53

2.15

mmol/l

0.73

269

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.37

0.44

1.3

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

130

1.31

0.43

1.4

1.5

—

(3004775) Volume in Urine collected for unspecified duration

426

0.84

0.43

2.1

2.3

645.39

629.47

0.14

292

(3023430) Cat dander IgE Ab [Units/volume] in Serum

252

0.79

0.43

1.2

1.1

2.89

3.72

u/ml

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

157

1.27

0.43

1.4

1.8

95.56

142.47

umol/l

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.61

0.43

1.8

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.61

0.43

1.8

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.61

0.43

1.8

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.43

0.42

1.6

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.66

0.42

1.3

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

102

1121

0.91

0.42

1.3

1.5

0.25

0.23

g/l

0.80

1064

(3011985) Renin [Units/volume] in Plasma

556

1.13

0.42

1.3

1.4

51.11

63.20

mu/l

0.44

497

(3006270) Folate [Moles/volume] in Blood

424

0.85

0.41

1.3

1.2

352.38

345.03

nmol/l

0.06

337

(3016879) Cocaine [Presence] in Urine

445

0.85

0.41

1.1

1.9

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.0

—

1.88

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.40

0.0

1.2

—

(3013762) Body weight Measured

0.00

0.40

0.0

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

539

1.13

0.40

1.1

1.3

0.10

0.39

nmol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

216

0.79

0.40

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

168

1.25

0.40

1.6

1.8

475.90

668.71

e6/l

1.80

161

(40768797) Stomach Pathology biopsy report

580

5596

1.04

0.40

1.3

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.36

0.40

1.3

1.5

—

(3011288) Drugs identified in Urine by Screen method

303

0.82

0.39

1.0

2.7

—

(3035933) Granulocytes/100 leukocytes in Blood

1.31

0.39

1.4

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

0.68

0.39

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

104

0.67

0.39

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.39

0.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

522

1.13

0.39

1.3

266.66

295.84

pmol/l

0.43

442

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

142

1.27

0.38

1.1

1.5

—

(3025577) Chromium [Mass/volume] in Blood

355

0.84

0.37

2.2

2.0

2.37

1.99

ug/l

0.34

292

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

373

1.15

0.37

1.2

94.59

95.85

0.10

350

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.35

0.37

1.2

1.1

8.80

9.95

u/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.35

0.37

1.6

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

365

0.85

0.37

1.1

2.07

1.05

u/ml

0.52

148

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

375

3592

1.05

0.37

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

254

2675

0.95

0.36

1.1

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

364

0.85

0.36

1.2

1.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.36

0.36

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.36

0.36

1.3

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

134

0.75

0.35

1.1

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

373

0.86

0.34

1.1

7.76

3.49

u/ml

0.56

174

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

178

0.79

0.34

1.6

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

436

0.87

0.34

1.1

4.05

1.52

u/ml

0.37

222

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.34

0.34

1.3

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.34

0.34

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.34

0.34

1.3

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.33

0.33

1.3

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

133

0.75

0.33

1.1

—

(3036180) Methadone [Presence] in Urine

0.70

0.33

1.7

1.5

—

(3008295) Osmolality of Serum or Plasma

388

1.13

0.32

1.3

1.4

273.29

277.97

mosm/kgh2o

0.89

292

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

742

1.09

0.31

1.4

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

305

0.85

0.31

1.1

1.2

—

3.71

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

457

4723

0.96

0.31

2.0

2.5

6.69

7.53

ug/l

0.41

389

4104

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

475

1.12

0.31

1.1

1.3

—

nmol/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

221

1.18

0.30

1.1

1.4

1.52

1.54

g/l

0.12

221

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

107

1150

0.93

0.30

1.3

1.5

1.13

1.18

g/l

0.80

101

1088

(3010726) Horse dander IgE Ab [Units/volume] in Serum

314

0.86

0.29

1.1

4.18

1.49

u/ml

0.50

155

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

259

1.16

0.29

1.2

1.5

15.07

14.16

umol/l

0.21

238

(3003129) Base excess in Capillary blood by calculation

130

0.77

0.29

1.0

1.5

-0.79

0.34

mmol/l

—

124

(3051387) C reactive protein [Mass/volume] in Capillary blood

982

0.93

0.29

3.8

3.6

27.92

27.72

mg/l

0.02

639

(3027008) Opiates [Presence] in Urine

471

0.89

0.28

1.1

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

216

0.83

0.28

2.3

2.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

966

9469

1.02

0.28

1.7

1.8

1127.02

1149.14

nmol/l

0.30

723

7097

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

172

0.81

0.27

1.1

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

247

0.85

0.27

1.4

1.3

1.10

1.23

nmol/l

0.29

184

(3019897) Erythrocyte distribution width [Ratio] by Automated count

309

1.13

0.26

6.0

3.2

13.41

13.29

0.29

304

(3004451) EKG impression Narrative

243

1.15

0.26

1.2

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.30

0.26

1.4

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

267

0.86

0.25

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

613

0.91

0.25

1.1

148.38

686.56

iu/ml

0.64

118

(3005033) Fetal Nuchal fold Thickness US

1.25

0.25

1.3

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.23

0.25

1.3

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

224

0.85

0.25

3.1

4.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

245

0.86

0.25

1.0

1.1

0.10

9.55

nmol/l

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

266

0.86

0.25

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

266

0.86

0.25

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

191

0.84

0.24

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.74

0.24

1.7

1.1

—

(3028300) Cannabinoids [Presence] in Urine

475

0.90

0.24

1.1

1.9

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

264

0.87

0.23

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

264

0.87

0.23

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

388

3991

0.97

0.22

1.6

1.8

1.60

1.55

0.48

328

3385

(3027456) Digoxin [Moles/volume] in Serum or Plasma

115

1087

1.06

0.22

3.0

3.1

0.79

0.84

nmol/l

0.50

853

(3001186) Copper [Moles/volume] in Serum or Plasma

1.25

0.22

1.1

1.2

18.15

15.59

umol/l

1.44

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

201

1929

1.04

0.22

3.0

2.9

4.34

4.40

pmol/l

0.40

180

1672

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.25

0.22

1.0

1.2

18.80

14.32

u/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.22

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.75

0.22

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.74

0.22

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

680

0.93

0.22

1.3

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

263

0.87

0.22

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

399

0.90

0.22

1.8

1.7

39.89

24.87

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1552

15698

0.98

0.21

4.1

3.8

20.61

24.42

20.00

775

7692

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

5.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

4.8

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

2.36

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

446.11

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.11

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

188

0.85

0.21

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(3020491) Glucose [Moles/volume] in Blood

325

0.89

0.21

1.7

2.3

7.14

6.89

mmol/l

0.19

218

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

502

0.92

0.21

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

209

0.86

0.21

1.2

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

0.23

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.24

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1024

10086

1.02

0.20

1.7

22183559.92

29673829.77

pmol/l

0.18

852

8206

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

134

0.82

0.20

1.1

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

697

0.93

0.20

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

0.00

0.20

0.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.22

0.20

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.22

0.20

2.3

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.22

0.20

2.3

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

509

1.08

0.20

1.2

4.30

3.23

u/ml

0.19

150

(3000764) Benzodiazepines [Presence] in Urine

469

0.92

0.20

1.1

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.20

0.19

1.5

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.20

0.19

1.7

4.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

193

1.14

0.19

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.18

0.19

1.0

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

134

1401

0.96

0.19

2.9

1.4

37.06

37.59

g/l

0.43

110

1181

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

154

0.84

0.19

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

637

1.07

0.18

1.5

1.3

16.48

8.60

u/l

2.60

508

(3029075) Extractable nuclear Ab panel - Serum

100

1.20

0.18

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

257

0.89

0.17

1.2

1.83

1.03

u/ml

0.19

147

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

173

0.87

0.16

2.3

2.2

57.86

55.93

umol/l

0.09

148

(3027944) Amphetamines [Presence] in Urine

464

0.93

0.16

1.1

1.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

319

0.91

0.16

1.2

74.00

171.94

titre

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

116

1210

0.96

0.16

2.9

1.5

0.00

g/l

-0.00

104

1096

(40757373) Influenza virus identified in Isolate

1.18

0.14

1.3

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

316

0.92

0.14

1.1

1.3

0.82

1.25

promille

0.87

239

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

139

0.86

0.14

3.9

1.7

224.50

159.75

1.30

130

(3044927) Protein electrophoresis panel - Urine

511

0.94

0.14

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

500

1.06

0.13

1.2

3.36

5.02

u/ml

0.95

223

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

151

1.13

0.13

8.6

5.6

71.73

69.94

0.12

129

(40768446) Kidney Pathology biopsy report

151

1.13

0.13

1.4

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

128

1324

0.97

0.13

3.1

1.4

0.01

0.03

g/l

0.55

113

1190

(40761535) Cells panel - Urine sediment

379

3858

0.98

0.13

3.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

148

0.88

0.12

1.9

82.06

50.71

ug/l

0.96

143

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

318

3239

0.98

0.12

3.2

3.9

92.25

97.48

ng/l

0.45

266

2727

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

143

1.12

0.11

5.9

7.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

536

0.95

0.10

1.1

1.2

215.76

193.24

miu/ml

0.11

201

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

341

0.94

0.10

2.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

125

1.12

0.10

5.8

7.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

144

1477

0.97

0.10

3.0

1.5

0.69

0.42

g/l

0.85

122

1249

(3021387) Prolactin [Units/volume] in Serum or Plasma

616

0.96

0.10

1.5

1.8

233.49

292.41

mu/l

1.76

569

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.11

0.09

8.4

3.9

70.20

41.79

ug/min

—

(40768443) Skin Pathology biopsy report

159

1627

0.98

0.09

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

120

1233

0.97

0.09

2.9

1.5

0.00

g/l

-0.00

105

1100

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.06

0.09

1.8

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

124

0.89

0.09

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

489

1.04

0.08

1.2

1.5

91.30

125.38

u/ml

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

1653

0.98

0.08

2.6

1.4

10.22

10.30

g/l

0.08

138

1423

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.06

0.08

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

133

0.90

0.07

1.2

—

0.09

—

(3010503) CD19 cells [#/volume] in Blood

137

1.09

0.07

1.4

2.0

0.07

0.14

e9/l

1.67

131

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.86

0.07

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.83

0.07

1.4

1.5

103.43

134.95

ng/l

—

(3004588) Protein electrophoresis panel - Serum or Plasma

317

3132

1.01

0.07

2.5

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

101

0.89

0.06

2.3

1.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

101

0.89

0.06

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

102

0.88

0.06

1.6

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

104

0.86

0.06

4.3

1.9

0.93

0.99

ug/l

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

264

0.95

0.06

1.6

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

139

1366

1.02

0.06

1.7

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

375

0.96

0.06

1.1

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

1768

0.99

0.03

2.7

1.4

3.68

3.76

g/l

0.40

151

1549

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

488

1.02

0.03

1.2

253.17

281.22

u/ml

0.29

309

(3026389) Candida sp identified in Specimen by Organism specific culture

498

1.02

0.03

1.2

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

108

0.93

0.03

1.1

1.3

—

1880525.00

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

176

1774

0.99

0.02

2.6

1.4

7.30

7.48

g/l

0.84

152

1554

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

430

1.02

0.02

3.1

3.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

176

1773

0.99

0.02

2.6

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

519

0.98

0.02

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

147

0.95

0.01

1.0

1.2

—

(3017704) Immunofixation for Urine

243

1.03

0.01

1.3

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

477

0.98

0.01

1.2

107.36

115.63

1.34

423

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

106

0.94

0.01

5.1

7.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

174

1.03

0.00

1.2

1.1

—

(3016750) Collection duration of Urine

286

0.98

0.00

2.0

501.16

496.85

min

0.08

220

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

166

1666

1.00

0.00

2.7

1.4

2.99

2.94

g/l

0.30

143

1447

(3020911) Cortisol [Moles/time] in 24 hour Urine

105

0.95

0.00

1.0

1.5

1571.77

78.84

nmol/24h

—

105

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

200

1.00

0.00

1.1

1.3

—

(44813793) Dust mix specific IgE antibody measurement

232

0.99

0.00

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

560

1.00

0.00

1.2

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

195

1.03

0.00

1.2

1.3

6.13

6.21

mmol/l

0.13

183

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

199

1.00

0.00

1.2

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

483

0.99

0.00

3.5

3.0

40.48

33.67

mg/l

0.23

362

(3016244) Insulin [Units/volume] in Serum or Plasma

135

1.04

0.00

2.4

3.1

23.65

21.58

mu/l

0.09

127

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.02

0.00

1.1

—

(3015183) Erythrocyte sedimentation rate

125

1.04

0.00

1.3

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.03

0.00

1.2

1.5

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

7.20

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1273.33

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

121.40

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.4

—

0.21

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.00

-0.00

1.2

1.5

56.40

44.02

umol/l

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

157.43

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.98

-0.00

1.8

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.98

-0.00

1.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.94

-0.00

2.8

1.8

14.12

18.07

umol/l

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.92

-0.00

1.0

1.1

123.25

100.03

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

3.78

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

3.9

—

18.14

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

2.02

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.91

-0.00

1.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.01

-0.00

1.0

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.02

-0.00

4.2

2.1

—

34.76

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.91

-0.00

1.1

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.00

-0.00

14.0

12.5

5.22

5.07

mmol/l

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.94

-0.00

1.2

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_RECTUM_WIDE – Malignant neoplasm of rectum, including Hilmo

GWS hits: 14

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of rectum, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of rectum, including Hilmo (C3_RECTUM_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints